Journal profile · Peripheral Vascular Disease
Current Hypertension Reports
ISSN 1522-6417 · eISSN 1534-3111 · Springer US · UNITED STATES · Bimonthly · Founded 1999
Current Hypertension Reports: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.35; hybrid open access; APC about USD 4,590; median 77 days to acceptance (47 articles, last 24 months); community-reported acceptance: moderate; 30 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Hypertension Reports is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Pressure and Hypertension Studies, Hormonal Regulation and Hypertension and Renin-Angiotensin System Studies, together about 45.8% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
This journal intends to provide clear, insightful, balanced contributions by international experts that review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of hypertension. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as antihypertensive therapies, associated metabolic disorders, and therapeutic trials. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Editor-in-chief John E. HallPublisher website
Editorial board by country: 2 in mainland China (about 4%); most named United States 21, Brazil 7, Japan 3, Mainland China 2, Germany 2 (48 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Pressure and Hypertension StudiesMedicine25%
- Hormonal Regulation and HypertensionMedicine13.2%
- Renin-Angiotensin System StudiesMedicine7.6%
- Sodium Intake and HealthNursing7.4%
- Heart Rate Variability and Autonomic ControlMedicine6.4%
- Cardiovascular Health and Disease PreventionMedicine4%
- Pregnancy and preeclampsia studiesMedicine3.3%
- Diet and metabolism studiesMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.35LetPub ·
- Impact factor (publisher) 2025
- 6.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.3Publisher website ·
- CiteScore 2026-06
- 12.5LetPub ·
- SJR 2026-06
- 2.16LetPub ·
- SNIP 2026-06
- 2.17LetPub ·
- h-index
- 63LetPub ·
- h-index
- 120OpenAlex ·
- i10-index
- 1,500OpenAlex ·
- 2-year mean citedness
- 6.16OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 41.74%LetPub ·
Volume
- Articles per year
- 29LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 589,200Publisher website ·
Articles by year OpenAlex count · 2,298 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 38 | 23 | 25 |
| 2025 | 30 | 16 | 118 |
| 2024 | 31 | 18 | 467 |
| 2023 | 58 | 28 | 1,121 |
| 2022 | 66 | 37 | 2,048 |
| 2021 | 43 | 23 | 1,183 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
77 daysMedian, submission to acceptance · P25–P75 39 days – 123 days
- Acceptance to online
- median 22 days (69 articles)
- Submission to online
- median 103 days
- Sample
- 47 articles with submission and acceptance dates (80 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 12 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,590 / EUR 3,590 / GBP 2,890 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted4
- commentaryReviews and Invited Commentaries Back to topLength not stated
- invited commentariesTypes of papers Reviews and Invited CommentariesLength not stated
- reviewReviews and Invited Commentaries Back to topLength not stated
- reviewsTypes of papers Reviews and Invited CommentariesLength not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
LLMs do not satisfy authorship criteria; use of LLMs must be documented in the Methods section. Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Conflict of interest
Authors must disclose financial or non-financial competing interests. Model summary
Authors must indicate whether or not they have a financial relationship with the organization that sponsored the research. This note should be added in a separate section before the reference list. If no conflict exists, authors should state: The authors declare that they have no conflict of interest. Back to top
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement explaining how to access supporting data. Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Ethical standards
The journal is a COPE member and follows COPE guidelines on misconduct. Model summary
Manuscripts submitted for publication must contain a statement to the effect that all human and animal studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. It should also be stated clearly in the text that all persons gave their informed conse…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
Open Choice articles retain copyright with the author and are published under a Creative Commons license. Model summary
To find out more about publishing your work Open Access in Current Hypertension Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1999
- ISSN
- 1522-6417
- Electronic ISSN
- 1534-3111
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Hypertension Reports
What CAS zone is Current Hypertension Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Hypertension Reports is in Zone 2 of Medicine, and in Zone 2 of the minor category Peripheral Vascular Disease. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Hypertension Reports?
The latest impact factor listed by LetPub is 6.35; CiteScore 12.5, h-index 120.
How long does peer review take at Current Hypertension Reports?
Based on the dates recorded on 47 articles published between September 2024 and September 2026 (the last 24 months), the median time from submission to acceptance is 77 days (interquartile range 39–123 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Hypertension Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Hypertension Reports based?
Of the 48 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are United States (21), Brazil (7) and Japan (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Hypertension Reports?
According to LetPub and DOAJ records, Current Hypertension Reports is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Current Hypertension Reports open access, and what is the APC?
Current Hypertension Reports is a hybrid journal. For open-access publication: APC about USD 4,590.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .